Paper16636679
Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival.
Sun C and 8 others. Oncogene, 2006. Cited by 72 papers, by iCite.
Cite this record
ConductScience Library. Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival. Papers, record 16636679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16636679
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Division | Major topic |
| Cell Survival | Major topic |
| Prostatic Neoplasms | Major topic |
| Receptors, Androgen | Major topic |
| Apoptosis | |
| Cell Line, Tumor | |
| Genes, p53 | |
| Genetic Vectors | |
| Humans | |
| Male | |
| Transcriptional Activation |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12089231 | Molecular biology of the androgen receptor. | J Clin Oncol | 2002 | https://conductscience.org/library/papers/12089231 | PubMed |
| 2 | 7671222 | Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. | Cancer Res | 1995 | https://conductscience.org/library/papers/7671222 | PubMed |
| 3 | 15540784 | Down-regulation of the prostate specific antigen promoter by p53 in human prostate cancer cells. | J Urol | 2004 | https://conductscience.org/library/papers/15540784 | PubMed |
| 4 | 9619361 | Update on the diagnosis and treatment of prostate cancer. | Curr Opin Oncol | 1998 | https://conductscience.org/library/papers/9619361 | PubMed |
| 5 | 7671257 | Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. | Cancer Res | 1995 | https://conductscience.org/library/papers/7671257 | PubMed |
| 6 | 11717329 | Androgen receptor signaling in androgen-refractory prostate cancer. | J Natl Cancer Inst | 2001 | https://conductscience.org/library/papers/11717329 | PubMed |
| 7 | 11156376 | HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. | Cancer Res | 2000 | https://conductscience.org/library/papers/11156376 | PubMed |
| 8 | 14702632 | Molecular determinants of resistance to antiandrogen therapy. | Nat Med | 2004 | https://conductscience.org/library/papers/14702632 | PubMed |
| 9 | 16007156 | Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP. | Oncogene | 2005 | https://conductscience.org/library/papers/16007156 | PubMed |
| 10 | 10618708 | mdm2: a bridge over the two tumour suppressors, p53 and Rb. | Oncogene | 1999 | https://conductscience.org/library/papers/10618708 | PubMed |
| 11 | 2260966 | A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. | Biochem Biophys Res Commun | 1990 | https://conductscience.org/library/papers/2260966 | PubMed |
| 12 | 9482916 | A simplified system for generating recombinant adenoviruses. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9482916 | PubMed |
| 13 | 15368466 | Epothilone induced cytotoxicity is dependent on p53 status in prostate cells. | Prostate | 2004 | https://conductscience.org/library/papers/15368466 | PubMed |
| 14 | 11888926 | Functional analysis of 44 mutant androgen receptors from human prostate cancer. | Cancer Res | 2002 | https://conductscience.org/library/papers/11888926 | PubMed |
| 15 | 7502427 | Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation. | Urology | 1995 | https://conductscience.org/library/papers/7502427 | PubMed |
| 16 | 11900250 | The development of androgen-independent prostate cancer. | Nat Rev Cancer | 2001 | https://conductscience.org/library/papers/11900250 | PubMed |
| 17 | 10200775 | Cancer statistics, 1999. | CA Cancer J Clin | 1999 | https://conductscience.org/library/papers/10200775 | PubMed |
| 18 | 14518029 | Molecular characterization of human prostate carcinoma cell lines. | Prostate | 2003 | https://conductscience.org/library/papers/14518029 | PubMed |
| 19 | 9622059 | Prostate-specific amplification of expanded polyglutamine expression: a novel approach for cancer gene therapy. | Cancer Res | 1998 | https://conductscience.org/library/papers/9622059 | PubMed |
| 20 | 15982869 | Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. | J Steroid Biochem Mol Biol | 2005 | https://conductscience.org/library/papers/15982869 | PubMed |
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42662529 | Asymmetric cross-reactivity of nuclear receptors reveals an evolutionary buffer between estrogen and androgen signaling. | iScience | 2026 | https://conductscience.org/library/papers/42662529 | PubMed |
| 40609538 | Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40609538 | PubMed |
| 40269952 | The role of androgens and global and tissue-specific androgen receptor expression on body composition, exercise adaptation, and performance. | Biol Sex Differ | 2025 | https://conductscience.org/library/papers/40269952 | PubMed |
| 38481034 | Discovery of Novel Anti-Resistance AR Antagonists Guided by Funnel Metadynamics Simulation. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38481034 | PubMed |
| 37189723 | Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy. | Biomedicines | 2023 | https://conductscience.org/library/papers/37189723 | PubMed |
| 36672609 | Androgen-Independent Prostate Cancer Is Sensitive to CDC42-PAK7 Kinase Inhibition. | Biomedicines | 2022 | https://conductscience.org/library/papers/36672609 | PubMed |
| 36660947 | STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide. | Mol Med Rep | 2023 | https://conductscience.org/library/papers/36660947 | PubMed |
| 36639570 | Computationally guided discovery of novel non-steroidal AR-GR dual antagonists demonstrating potency against antiandrogen resistance. | Acta Pharmacol Sin | 2023 | https://conductscience.org/library/papers/36639570 | PubMed |
| 36459502 | Yeast-based evolutionary modeling of androgen receptor mutations and natural selection. | PLoS Genet | 2022 | https://conductscience.org/library/papers/36459502 | PubMed |
| 36017332 | Simulating androgen receptor selection in designer yeast. | Synth Syst Biotechnol | 2022 | https://conductscience.org/library/papers/36017332 | PubMed |
| 35573198 | High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice. | iScience | 2022 | https://conductscience.org/library/papers/35573198 | PubMed |
| 35015785 | Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model. | PLoS One | 2022 | https://conductscience.org/library/papers/35015785 | PubMed |
| 34193425 | In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer. | Sci Adv | 2021 | https://conductscience.org/library/papers/34193425 | PubMed |
| 31379747 | Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2. | Front Endocrinol (Lausanne) | 2019 | https://conductscience.org/library/papers/31379747 | PubMed |
| 30565014 | A Targeted Bivalent Androgen Receptor Binding Compound for Prostate Cancer Therapy. | Horm Cancer | 2019 | https://conductscience.org/library/papers/30565014 | PubMed |
| 30027434 | Androgenic modulation of AR-Vs. | Endocrine | 2018 | https://conductscience.org/library/papers/30027434 | PubMed |
| 28876465 | Procyanidin B2 3,3″-di-O-gallate induces oxidative stress-mediated cell death in prostate cancer cells via inhibiting MAP kinase phosphatase activity and activating ERK1/2 and AMPK. | Mol Carcinog | 2018 | https://conductscience.org/library/papers/28876465 | PubMed |
| 28235766 | Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer. | Cancer Res | 2017 | https://conductscience.org/library/papers/28235766 | PubMed |
| 27741508 | Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles. | Oncotarget | 2017 | https://conductscience.org/library/papers/27741508 | PubMed |
| 27302572 | Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic. | Int J Urol | 2016 | https://conductscience.org/library/papers/27302572 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AR | 367 | PubTator's text mining | https://conductscience.org/library/genes/367 | NCBI Gene |
| RIEG2 | 6012 | PubTator's text mining | https://conductscience.org/library/genes/6012 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16636679
GET https://conductscience.org/api/papers/v1/16636679/references?page=2